Cargando…

A Rare Case of Pertuzumab-Induced Toxic Epidermal Necrolysis

Pertuzumab is a targeted therapy drug that is employed in the management of human epidermal growth factor receptor 2 (HER2)-positive breast cancer and works by blocking the ability of cancer cells to receive growth and proliferation signals. Toxic epidermal necrolysis (TEN) is a severe cutaneous man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed Jiffry, Mohamed Zakee, Carmona Pires, Felipe, Perozo, Maria A, Rangsipat, Napat, Tabares, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313340/ https://www.ncbi.nlm.nih.gov/pubmed/37398793 http://dx.doi.org/10.7759/cureus.39797

Ejemplares similares

BK-Virus-Induced Hemorrhagic Cystitis in a Patient With Graft-Versus-Host Disease
por: Mohamed Jiffry, Mohamed Zakee, et al.
Publicado: (2023)

A Rare Case of Neural Epidermal Growth Factor-Like 1 Protein (NELL-1) Antigen-Associated Membranous Nephropathy
por: Mohamed Jiffry, Mohamed Zakee, et al.
Publicado: (2023)

Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon
por: Pamnani, Soumya, et al.
Publicado: (2022)

A Rare Case of Acute Liver Failure Secondary to Miliary Liver Metastasis
por: Weeraddana, Prabasha, et al.
Publicado: (2022)

The Reflection on the Management of Toxic Epidermal Necrolysis in the Community Setting: An Internist's Perspective
por: Zhang, Qian, et al.
Publicado: (2021)

A Case of Plasmablastic Multiple Myeloma With Extramedullary Disease Manifesting as a Myelomatous Pleural Effusion
por: Mohamed Jiffry, Mohamed Zakee, et al.
Publicado: (2022)

Phenytoin-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap in Focus: A Case Report
por: Puri, Piyush, et al.
Publicado: (2023)

Anaplastic Large-Cell Lymphoma (ALCL) First Manifested as a Rapidly Progressive Acute Respiratory Failure (RF): Lymph Node Biopsy Negative Presentation Posing a Diagnostic Challenge
por: Weeraddana, Prabasha, et al.
Publicado: (2023)

Agranulocytosis Secondary to Cancer Chemotherapy Associated With Higher In-Hospital Mortality in Patients With Central Line Insertion During a Hospital Stay
por: Mohamed Jiffry, Mohamed Z, et al.
Publicado: (2023)

Sickle Cell Anemia Associated With Increased In-Hospital Mortality in Post-Cardiac Arrest Patients
por: Mohamed Jiffry, Mohamed Zakee, et al.
Publicado: (2023)

Metformin-Induced Hemolysis in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Presenting With Concurrent Idiopathic Steven-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Roy Choudhury, Avijoy, et al.
Publicado: (2021)

Early Manifestations of Toxic Epidermal Necrolysis
por: Chapman, James, et al.
Publicado: (2017)

Toxic Epidermal Necrolysis induced by rarely implicated drugs
por: Rajagopalan, Sujit, et al.
Publicado: (2012)

Levofloxacin-Induced Toxic Epidermal Necrolysis
por: Khan, Andeebia A, et al.
Publicado: (2023)

Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Dobry, Allison S., et al.
Publicado: (2022)

Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014)

Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016)

Carbamzepine-induced toxic epidermal necrolysis
por: Chowta, Nithyananda K., et al.
Publicado: (2011)

Ofloxacin-induced toxic epidermal necrolysis
por: Gupta, Gaurang
Publicado: (2014)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Fulvestrant-induced toxic epidermal necrolysis
por: Morales-Conde, Macarena, et al.
Publicado: (2019)

Allopurinol-Induced Toxic Epidermal Necrolysis
por: Buenrostro-Rubio, Ignacio, et al.
Publicado: (2019)

Pembrolizumab-Induced Toxic Epidermal Necrolysis
por: Borg, Luca, et al.
Publicado: (2022)

Phenytoin-Induced Toxic Epidermal Necrolysis
por: Tunuguntla, Mounika Nagarani, et al.
Publicado: (2023)

Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Yan, Qingzi, et al.
Publicado: (2023)

Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Tsukagoshi, Eri, et al.
Publicado: (2021)

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in Brazil
por: Wakamatsu, Tais Hitomi, et al.
Publicado: (2021)

Review of Toxic Epidermal Necrolysis
por: Harris, Victoria, et al.
Publicado: (2016)

Toxic Epidermal Necrolysis and Sepsis
por: Alves, Daniela Dias, et al.
Publicado: (2016)

Oxcarbazepine induced toxic epidermal necrolysis - a rare case report
por: Guleria, Vivek S., et al.
Publicado: (2015)

A rare presentation of enfortumab vedotin–induced toxic epidermal necrolysis
por: Francis, Andrea, et al.
Publicado: (2020)

Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan
por: Hsieh, Ming-Hsiu, et al.
Publicado: (2021)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

Diagnostic dilemma in a patient presenting with thrombotic microangiopathy in the setting of pregnancy
por: Jiffry, Mohamed Zakee Mohamed, et al.
Publicado: (2022)

Rapidly Developing Toxic Epidermal Necrolysis
por: Poulsen, Viktoria Oline Barrios, et al.
Publicado: (2013)

Toxic epidermal necrolysis in hemodialysis patient
por: Mateti, Uday Venkat, et al.
Publicado: (2015)

Immune-Mediated Toxic Epidermal Necrolysis
por: Keerty, Dinesh, et al.
Publicado: (2020)

Toxic Epidermal Necrolysis Secondary to Metronidazole
por: Ali, Junaid, et al.
Publicado: (2021)

Pneumonia caused by toxic epidermal necrolysis
por: Doyle, Dominic, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nfejtge2itp9n23muai29m6np7